First, I want to apologize for not being able to keep up with my blog as much as I would like, or to share as much in public as I would prefer. The reasons are twofold. We’ve been very busy at Kyield, and testing has increasingly confirmed that while competitors in our industry invest heavily in web information (CI), most customers do not; at least for enterprise-wide systems like Kyield. So I have regrettably pulled back on detailed public writing, or rather– have replaced with more formal papers and presentations with customers.
A good example of our efforts is the new report below, which is a hybrid of an academic paper with citations supporting our claims and a detailed brochure for senior managers in pharmaceuticals, biotech, and healthcare–particularly those pursuing personalized medicine and significant improvement in operational efficiency:
The paper highlights the challenges facing the industry with considerable detail on how Kyield is unique in the world with respect to ability to overcome these challenges. Essentially, in order to overcome systemic challenges it requires a systemic solution, and in terms of distributed organizations it requires a very particular type of systemic solution that can address each of the challenges. Due to the high values involved, the result is that Kyield may well be the best investment option in the world today for life science executives.
For those who would prefer more frequent updates, the best methods to track either Kyield or my activity are as follows:
And of course visit our web site regularly at www.kyield.com